BofA Lowers McKesson (MCK) Price Target, Flags GLP-1 Pricing Pressure

McKesson Corporation (NYSE:MCK) is included among the 15 Best Consistent Dividend Stocks to Buy Right Now.

BofA Lowers McKesson (MCK) Price Target, Flags GLP-1 Pricing Pressure

On April 6, BofA analyst Allen Lutz lowered the firm’s price recommendation on McKesson Corporation (NYSE:MCK) to $1,000 from $1,040. It reiterated a Buy rating on the shares. The analyst said the rapid decline in cash-pay GLP-1 prices is shifting prescriptions away from insurance. At the same time, strong growth in cash-pay scripts for Wegovy and Zepbound could weigh on McKesson’s FY27 EBIT guidance in the Prescription Technology Solutions segment, potentially coming in below Street expectations.

Earlier in March, the company said Britt Vitalone, Executive Vice President and Chief Financial Officer, has decided to retire after a 20-year career with McKesson, including more than eight years as CFO. Kenny Cheung is set to join the company as Executive Vice President and CFO, effective May 29, 2026.

Vitalone will remain involved with McKesson after stepping down as CFO. He will serve as a strategic advisor to help ensure a smooth transition and to support the planned separation of McKesson’s Medical Surgical Solutions business.

McKesson Corporation (NYSE:MCK) operates as a diversified healthcare services company focused on improving patient outcomes. Its US Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter drugs, along with other healthcare-related products across the United States.

While we acknowledge the risk and potential of MCK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MCK and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Cheapest Stocks with Highest Dividends and 14 Cheap DRIP Stocks to Buy Now

Disclosure: None. Follow Insider Monkey on Google News.